INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions

IUBMB Life

Volumn 59, Issue 7, 2007, Pages 419-426

  Cánepa, Eduardo T ^a   Scassa, María E ^a   Ceruti, Julieta M ^a   Marazita, Mariela C ^a   Carcagno, Abel L ^a   Sirkin, Pablo F ^a   Ogara, María F ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Apoptosis; Cancer; Cell cycle; DNA repair; INK4; Senescence

Indexed keywords

ANKYRIN; CYCLIN D; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLIN DEPENDENT KINASE INHIBITOR 2C; CYCLIN DEPENDENT KINASE INHIBITOR 2D; PROTEIN P16INK4A; SCLEROPROTEIN; TRANSCRIPTION FACTOR E2F1;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL GROWTH; CELL LINEAGE; DNA REPAIR; GENETIC VARIABILITY; HUMAN; MITOGENESIS; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SENESCENCE; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; DNA REPAIR; HUMANS; MULTIGENE FAMILY;

MAMMALIA;

EID: 34547223720     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540701488358     Document Type: Review

References (64)

1. Roussel, M. F. (1999) The INK4 family of cell cycle inhibitors in cancer. Oncogene 18, 5311-5317.
2. Malumbres, M. and Barbacid, M. (2001) To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1, 222-231.
3. Massague, J. (2004) G1 cell-cycle control and cancer. Nature 432, 298-306.
4. Sherr, C. J., and Roberts, J. M. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
5. Harbour, J. W., Luo, R. X., Dei Santi, A., Postigo, A. A., and Dean, D. C. (1999) Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859-869.
6. Trimarchi, J. M., and Lees, J. A. (2002) Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell. Biol. 3, 11-20.
7. Pei, X. H., and Xiong, Y. (2005) Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 24, 2787-2795.
8. Ortega, S., Malumbres, M., and Barbacid, M. (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602, 73-87.
9. Kim, W. Y., and Sharpless, N. E. (2006) The regulation of INK4/ARF in cancer and aging. Cell 127, 265-275.
10. Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H., and DePinho, R. A. (2004) The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene 23, 379-3785.
11. Bardeesy, N., Aguirre, A. J., Chu, G. C., Cheng, K. H., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C., Weissleder, R., Mahmood, U., Hanahan, D., Redston, M. S., Chin, L., and Depinho, R. A. (2006) Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc. Natl. Acad. Sci. USA 103, 5947-5952.
12. Matheu, A., Pantoja, C., Efeyan, A., Criado, L. M., Martin-Caballero, J., Flores, J. M., Klatt, P., and Serrano, M. (2004) Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev. 18, 2736-2746.
13. Ruas, M., and Peters, G. (1998) The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378, F115-177.
14. Forbes, S., Clements, J., Dawson, E., Bamford, S., Webb, T., Dogan, A., Flanagan, A., Teague, J., Wooster, R., Futreal, P. A., and Stratton, M. R. (2006) Cosmic 2005. Br. J. Cancer 94, 318-322.
15. Esteller,M., Corn, P. G., Baylin, S. B., and Herman, J. G. (2001) A gene hypermethylation profile of human cancer. Cancer Res. 61, 3225-3229.
16. Aggerholm, A., Holm, M. S., Guldberg, P., Olesen, L. H., and Hokland, P. (2006) Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Eur. J. Haematol. 76, 23-32.
17. Bai, F., Pei, X. H., Godfrey, V. L., and Xiong, Y. (2003) Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol. Cell. Biol. 23, 1269-1277.
18. Matsuzaki, Y., Takaoka, Y., Hitomi, T., Nishino, H., and Sakai, T. (2004) Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c). Oncogene 23, 5409-5414.
19. Virchis, A., Ganeshaguru, K., Hart, S., Jones, D., Fletcher, L., Wright, F., Wickremasinghe, R., Man, A., Csermak, K., Meyer, T., Fabbro, D., Champain, K., Yap, A., Prentice, H. G., and Mehta, A. (2002) A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C. Hematol. J. 3, 131-126.
20. Sanchez-Aguilera, A., Delgado, J., Camacho, F. I., Sanchez-Beato, M., Sanchez, L., Montalban, C., Fresno, M. F., Martin, C., Piris, M. A., and Garcia, J. F. (2004) Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas. Blood 103, 2351-2357.
21. Uziel, T., Zindy, F., Xie, S., Lee, Y., Forget, A., Magdaleno, S., Rehg, J. E., Calabrese, C., Solecki, D., Eberhart, C. G., Sherr, S. E., Plimmer, S., Clifford, S. C., Hatten, M. E., McKinnon, P. J., Gilbertson, R. J., Curran, T., Sherr, C. J., and Roussel, M. F. (2005) The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev. 19, 2656-2667.
22. Zindy, F., den Besten, W., Chen, B., Rehg, J. E., Latres, E., Barbacid, M., Pollard, J. W., Sherr, C. J., Cohen, P. E., and Roussel, M. F. (2001) Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d). Mol. Cell. Biol. 21, 3244-3255.
23. Zindy, F., van Deursen, J., Grosveld, G., Sherr, C. J., and Roussel, M. F. (2000) INK4d-deficient mice are fertile despite testicular atrophy. Mol. Cell. Biol. 20, 372-378.
24. Bartkova, J., Thullberg, M., Rajpert-De Meyts, E., Skakkebaek, N. E., and Bartek, J. (2000) Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis. Oncogene 19, 4146-4150.
25. Gil, J., and Peters, G. (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell. Biol. 7, 667-677.
26. Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., and Serrano, M. (2006) Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 440, 702-706.
27. Kirchmaier, A. L., and Rine, J. (2006) Cell cycle requirements in assembling silent chromatin in Saccharomyces cerevisiae. Mol. Cell. Biol. 26, 852-862.
28. Karakaidos, P., Taraviras, S., Vassiliou, L. V., Zacharatos, P., Kastrinakis, N. G., Kougiou, D., Kouloukoussa, M., Nishitani, H., Papavassiliou, A. G., Lygerou, Z., and Gorgoulis, V. G. (2004) Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability - evidence of E2F-1 transcriptional control over hCdt1. Am. J. Pathol. 165, 1351-1365.
29. Murphy, N., Ring, M., Heffron, C. C., King, B., Killalea, A. G., Hughes, C., Martin, C. M., McGuinness, E., Sheils, O., and O'Leary, J. J. (2005) p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J. Clin. Pathol. 58, 525-534.
30. Campisi, J. (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522.
31. Kim, S. H., Kaminker, P., and Campisi, J. (2002) Telomeres, aging and cancer: in search of a happy ending. Oncogene 21, 503-511.
32. Ben-Porath, I., and Weinberg, R. A. (2005) The signals and pathways activating cellular senescence. Int. J. Biochem. Cell. Biol. 37, 961-976.
33. Zindy, F., Quelle, D. E., Roussel, M. F., and Sherr, C. J. (1997) Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15, 203-211.
34. Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguria, A., Zaballos, A., Flores, J. M., Barbacid, M., Beach, D., and Serrano, M. (2005) Tumour biology: senescence in premalignant tumours. Nature 436, 642.
35. Zhang, R., Poustovoitov, M. V., Ye, X., Santos, H. A., Chen, W., Daganzo, S. M., Erzberger, J. P., Serebriiskii, I. G., Canutescu, A. A., Dunbrack, R. L., Pehrson, J. R., Berger, J. M., Kaufman, P. D., and Adams, P. D. (2005) Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 8, 19-30.
36. Zhang, R., Chen, W., and Adams, P. D. (2007) Molecular dissection of formation of senescence-associated heterochromatin foci. Mol. Cell. Biol. 27, 2343-2358.
37. Narita, M., Narita, M., Krizhanovsky, V., Nunez, S., Chicas, A., Hearn, S. A., Myers, M. P., and Lowe, S. W. (2006) A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126, 503-514.
38. Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., and Sharpless, N. E. (2004) Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299-307.
39. Ohtani, N., Zebedee, Z., Huot, T. J., Stinson, J. A., Sugimoto, M., Ohashi, Y., Sharrocks, A. D., Peters, G., and Hara, E. (2001) Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409, 1067-1070.
40. Ressler, S., Bartkova, J., Niederegger, H., Bartek, J., Scharffetter-Kochanek, K., Jansen-Durr, P., and Wlaschek, M. (2006) p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 5, 379-389.
41. Raaphorst, F. M. (2005) Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors. Hum. Mol. Genet. 14 Spec No. 1, R93-R100.
42. Bracken, A. P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C., Theilgaard-Monch, K., Minucci, S., Porse, B. T., Marine, J. C., Hansen, K. H., and Helin, K. (2007) The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 21, 525-530.
43. Zhu, D., Xu, G., Ghandhi, S., and Hubbard, K. (2002) Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: implications for cellular senescence. J. Cell. Physiol. 193, 19-25.
44. Wang, W., Martindale, J. L., Yang, X., Chrest, F. J., and Gorospe, M. (2005) Increased stability of the p16 mRNA with replicative senescence. EMBO Rep. 6, 158-164.
45. Finkel, T. (2003) Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247-254.
46. Takahashi, A., Ohtani, N., Yamakoshi, K., Iida, S., Tahara, H., Nakayama, K., Nakayama, K. I., Ide, T., Saya, H., and Hara, E. (2006) Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat. Cell Biol. 8, 1291-1297.
47. Campisi, J. (2003) Cancer and ageing: rival demons? Nat. Rev. Cancer 3, 339-349.
48. Krtolica, A. (2005) Stem cell: balancing aging and cancer. Int. J. Biochem. Cell. Biol. 37, 935-941.
49. Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., and Scadden, D. T. (2006) Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443, 421-426.
50. Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., and Sharpless, N. E. (2006) p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443, 453-457.
51. Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., and Morrison, S. J. (2006) Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448-452.
52. Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G. C., Lukas, J., and Jackson, S. P. (2006) ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8, 37-45.
53. Sancar, A., Lindsey-Boltz, L. A., Unsal-Kacmaz, K., and Linn, S. (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73, 39-85.
54. Zhivotovsky, B., and Kroemer, G. (2004) Apoptosis and genomic instability. Nat. Rev. Mol. Cell. Biol. 5, 752-762.
55. Norbury, C. J., and Zhivotovsky, B. (2004) DNA damage-induced apoptosis. Oncogene 23, 2797-808.
56. Hickman, M. J., and Samson, L. D. (2004) Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine. Mol. Cell 14, 105-116.
57. Al-Mohanna, M. A., Manogaran, P. S., Al-Mukhalafi, Z. K., Al-Hussein, A., and Aboussekhra, A. (2004) The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene 23, 201-212.
58. Le, H. V., Minn, A. J., and Massague, J. (2005) Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells. J. Biol. Chem. 280, 32018-32025.
59. Bianchi, T., Rufer, N., MacDonald, H. R., and Migliaccio, M. (2006) The tumor suppressor p16Ink4a regulates T lymphocyte survival. Oncogene 25, 4110-4115.
60. Ceruti, J. M., Scassa, M. E., Flo, J. M., Varone, C. L., and Cánepa, E. T. (2005) Induction of p19INK4d in response to ultraviolet light improves DNA repair and confers resistance to apoptosis in neuroblastoma cells. Oncogene 24, 4065-4080.
61. Scassa, M. E., Marazita, M. C., Ceruti, J. M., Carcagno, A. L., Sirkin, P. F., Gonzalez-Cid, M., Pignataro, O. P., and Cánepa, E. T. (2007) Cell cycle inhibitor, p19INK4d, promotes cell survival and decreases chromosomal aberrations after genotoxic insult due to enhanced DNA repair. DNA Repair (Amst) 6, 626-638.
62. Tavera-Mendoza, L., Wang, T. T., Lallemant, B., Zhang, R., Nagai, Y., Bourdeau, V., Ramirez-Calderon, M., Desbarats, J., Mader, S., and White, J. H. (2006) Convergence of vitamin D and retinoic acid signalling at a common hormone response element. EMBO Rep. 7, 180-185.
63. Tavera-Mendoza, L. E., Wang, T. T., and White, J. H. (2006) p19INK4D and cell death. Cell Cycle 5, 596-598.
64. Bernstein, C., Bernstein, H., Payne, C. M., and Garewal, H. (2002) DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res. 511, 145-178.